We recently published a list of 11 Best NASDAQ Penny Stocks To Buy Right Now. In this article, we are going to look at where ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $78.41 which represents a slight increase of $0.69 or 0.89% from the prior close of $77.72. The stock opened at $78.09 and touched a low ...

Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...

Bearish flow noted in DexCom (DXCM) with 11,940 puts trading, or 4x expected. Most active are 12/27 weekly 59 puts and 12/27 weekly 77 puts, ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...

The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 3.05% during the third quarter of 2024. Read more here.

Several years ago, my insurance plan would only cover Admelog insulin to treat my type 1 diabetes, which caused my blood sugar to hover high for months. In the long term, prolonged high blood sugars ...

In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...

Canaccord analyst William Plovanic raised the firm’s price target on DexCom (DXCM) to $99 from $89 and keeps a Buy rating on the shares.